Ocular Therapeutix, Inc. (OCUL)
10.78
-0.30
(-2.66%)
USD |
NASDAQ |
Aug 24, 16:00
10.78
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Debt to Equity Ratio : 0.1526 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1526 |
| March 31, 2026 | 0.1366 |
| December 31, 2025 | 0.1176 |
| September 30, 2025 | 0.2982 |
| June 30, 2025 | 0.2515 |
| March 31, 2025 | 0.2866 |
| December 31, 2024 | 0.2403 |
| September 30, 2024 | 0.2134 |
| June 30, 2024 | 0.1983 |
| March 31, 2024 | 0.1824 |
| December 31, 2023 | 0.915 |
| September 30, 2023 | 10.57 |
| June 30, 2023 | 20.98 |
| March 31, 2023 | 6.653 |
| December 31, 2022 | 1.817 |
| September 30, 2022 | 1.108 |
| June 30, 2022 | 0.7847 |
| March 31, 2022 | 0.652 |
| December 31, 2021 | 0.6703 |
| September 30, 2021 | 0.6043 |
| June 30, 2021 | 0.6624 |
| March 31, 2021 | 0.6787 |
| December 31, 2020 | 0.768 |
| September 30, 2020 | -13.15 |
| June 30, 2020 | 10.79 |
| Date | Value |
|---|---|
| March 31, 2020 | -5.388 |
| December 31, 2019 | -16.35 |
| September 30, 2019 | 5.036 |
| June 30, 2019 | 7.080 |
| March 31, 2019 | 2.191 |
| December 31, 2018 | 0.691 |
| September 30, 2018 | 0.3112 |
| June 30, 2018 | 0.3418 |
| March 31, 2018 | 0.3474 |
| December 31, 2017 | 0.689 |
| September 30, 2017 | 0.4988 |
| June 30, 2017 | 0.371 |
| March 31, 2017 | 0.2773 |
| December 31, 2016 | 0.3008 |
| September 30, 2016 | 0.2496 |
| June 30, 2016 | 0.2194 |
| March 31, 2016 | 0.1917 |
| December 31, 2015 | 0.1705 |
| September 30, 2015 | 0.1531 |
| June 30, 2015 | 0.1379 |
| March 31, 2015 | 0.2872 |
| December 31, 2014 | 0.2533 |
| September 30, 2014 | 0.2252 |
| June 30, 2014 | 2.984 |
| March 31, 2014 | 0.1863 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| EyePoint, Inc. | 0.1344 |
| LENZ Therapeutics, Inc. | 0.0026 |
| Merck & Co., Inc. | 1.286 |
| Theravance Biopharma, Inc. | 0.2463 |
| ANI Pharmaceuticals, Inc. | 1.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 671.32M |
| Total Liabilities (Quarterly) | 151.28M |
| Shareholders Equity (Quarterly) | 520.04M |
| Current Ratio | 13.10 |
| Net Debt Paydown Yield | -0.03% |